throbber
1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE SOUTHERN DISTRICT OF CALIFORNIA
`
`HONORABLE MICHAEL M. ANELLO, DISTRICT JUDGE
`
`_____________________________
`)
`MEDTRONIC SOFAMOR DANEK, USA ) CASE NO. 08 CV 1512-MMA
`ET AL.,
`)
`)
`)
`)
`) AUGUST 30, 2011
`)
`) TUESDAY, 8:30 AM
`)
`) TRIAL - DAY ONE
`DEFENDANT.
`_____________________________)
`
`PLAINTIFF,
`
`VS.
`
`NUVASIVE, INC.,
`
`
`
`
`
`REPORTER'S TRANSCRIPT OF PROCEEDINGS
`
`APPEARANCES:
`
`FOR THE PLAINTIFF:
`
`
`
`
`
`FOR THE DEFENDANT:
`
`LUKE L. DAUCHOT, ESQ.
`NIMALKA WICKRAMASEKERA, ESQ.
`SHARRE LOTFOLLAHI, ESQ.
`ALEXANDER F. MACKINNON, ESQ.
`MICHAEL DOBSZEWICZ, ESQ.
`KIRKLAND & ELLIS, LLP
`
`JEFF SCHWARTZ, ESQ.
`DEWEY & LEBOEUF
`
`FRANK SCHERKENBACH, ESQ.
`TODD G. MILLER, ESQ.
`JONATHAN J. LAMBERSON, ESQ.
`NEIL WARREN, ESQ.
`KEELEY I. VEGA, ESQ.
`FISH & RICHARDSON, P.C.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`WARSAW2041
`NuVasive, Inc. v. Warsaw Orthopedic, Inc.
`Case IPR2013-00206
`
`Page 1
`
`

`

` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` 2
`
`INDEX - 08 CV 1512
`
`MEDTRONIC V. NUVASIVE, 8/30/11
`
`
`
`WITNESSES:
`
`DR. GARY CARLIN MICHELSON
`
`
`
`
`
`OPENING STATEMENTS BY MR. DAUCHOT
`
`OPENING STATEMENTS BY MR. SCHERKENBACH
`
`
`
`PAGE:
`
` 110
`
` 39
`
` 80
`
`COURT'S PRELIMINARY INSTRUCTIONS
`
` 30
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 2
`
`

`

` 121
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Q
`
`A
`
`Q
`
`DR. MICHELSON, I DON'T SEE TRANSLATERAL UP THERE?
`
`THAT'S CORRECT.
`
`LET'S SPEAK ABOUT THE TERM TRANSLATERAL. THAT'S A TERM
`
`IN OPENING STATEMENT WE SAW IN THE CONTEXT OF YOUR '973
`
`PATENT.
`
`TO YOUR KNOWLEDGE, WAS THAT A TERM SPECIFICALLY IN
`
`THIS AREA THAT EXISTED BEFORE THE TIME THAT YOU INVENTED
`
`THIS IMPLANT?
`
`A
`
`WELL TO THE BEST OF MY KNOWLEDGE, I ACTUALLY CREATED
`
`THAT WORD. WITH THE IDEA OF THE TRANSCONTINENTAL RAILROAD
`
`IN MIND, THAT'S WHY I PICKED THE WORD TRANSLATERAL THAT
`
`TRANSCONTINENTAL RAILROAD CONNECTED THE ATLANTIC OCEAN TO
`
`THE PACIFIC OCEAN AND CROSSED THE ENTIRE CONTINENT AND MY
`
`CONCEPT OF A TRANSLATERAL IMPLANT WAS AN IMPLANT THAT WOULD
`
`ACTUALLY BE CAPABLE OF SITTING ON THIS APOPHYSEAL RING ON
`
`ONE SIDE AND GOING ALL THE WAY ACROSS AND SITTING ON THE
`
`APOPHYSEAL RING ON THE OPPOSITE SIDE.
`
`Q
`
`CAN WE PUT UP SLIDE FIVE, DAVE? CAN YOU PRESS.
`
`DOES THAT DEPICT TRANSLATERAL AS YOU USED IT IN
`
`YOUR '973 PATENT.
`
`A
`
`YES. AND ALSO ONE OTHER THING. IT'S COMING IN
`
`ESSENTIALLY PERPENDICULAR TO WHAT WE CALL THAT MID SAGITTAL
`
`LINE, SO WHILE THIS WAS THE FRONT AND THAT WAS THE BACK AND
`
`THINGS WENT IN FRONT TO BACK, THIS IS COMING IN AT 90 DEGREE
`
`ANGLE TO THE OLD TECHNOLOGY.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 3
`
`

`

` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE SOUTHERN DISTRICT OF CALIFORNIA
`
`HONORABLE MICHAEL M. ANELLO, DISTRICT JUDGE
`
`_____________________________
`)
`MEDTRONIC SOFAMOR DANEK, USA ) CASE NO. 08 CV 1512-MMA
`ET AL.,
`)
`)
`)
`)
`) AUGUST 31, 2011
`)
`) WEDNESDAY, 9:00 AM
`)
`) TRIAL - DAY TWO
`DEFENDANT.
`_____________________________)
`
`PLAINTIFF,
`
`VS.
`
`NUVASIVE, INC.,
`
`
`
`
`
`REPORTER'S TRANSCRIPT OF PROCEEDINGS
`
`APPEARANCES:
`
`FOR THE PLAINTIFF:
`
`
`
`
`FOR THE DEFENDANT:
`
`
`
`LUKE L. DAUCHOT, ESQ.
`NIMALKA WICKRAMASEKERA, ESQ.
`SHARRE LOTFOLLAHI, ESQ.
`ALEXANDER F. MACKINNON, ESQ.
`MICHAEL DOBSZEWICZ, ESQ.
`KIRKLAND & ELLIS, LLP
`
`JEFF SCHWARTZ, ESQ.
`DEWEY & LEBOEUF
`
`FRANK SCHERKENBACH, ESQ.
`TODD G. MILLER, ESQ.
`JONATHAN J. LAMBERSON, ESQ.
`NEIL WARREN, ESQ.
`KEELEY I. VEGA, ESQ.
`FISH & RICHARDSON, P.C.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
`
`Page 4
`
`

`

`INDEX - 08 CV 1512
`
`MEDTRONIC V. NUVASIVE, 8/31/11
`
` 185
`
`
`
`WITNESSES:
`
`DR. GARY KARLIN MICHELSON
`
`DIRECT BY MR. DAUCHOT
`
`CROSS BY MR. SCHERKENBACH
`
`REDIRECT BY MR. DAUCHOT
`
`RECROSS BY MR. SCHERKENBACH
`
`REDIRECT BY MR. DAUCHOT
`
`PAGE:
`
` 189
`
` 233
`
` 282
`
` 294
`
` 304
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
`
`Page 5
`
`

`

` 195
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Q
`
`EXPLAIN TO US WHAT RETROPERITONEAL LATERAL APPROACH TO
`
`THE SPINE WAS?
`
`A
`
`YES. SO I HAD MENTIONED YESTERDAY THAT IN DAYS GONE
`
`BY, SURGEONS WOULD SOMETIMES MAKE AN INCISION RIGHT THERE IN
`
`THE MIDDLE OF THE ABDOMEN AND GO STRAIGHT THROUGH WHERE THE
`
`INTESTINES ARE AND EVERYTHING ELSE, MOVE THOSE OUT OF THE
`
`WAY, AND GET TO THE SPINE.
`
`BUT ALL THOSE ORGANS ARE SITTING IN WHAT LOOKS
`
`LIKE A DUFFEL BAG, AND WE CALL THAT THE "PERITONEAL CAVITY."
`
`SO AS SURGEONS WHO DID THE ACCESS, LIKE VASCULAR
`
`SURGEONS, GOT MORE SKILLFUL AND MORE FAMILIAR WITH DOING
`
`SURGERY FOR SPINE SURGEONS, THEY LEARNED TO GO AROUND THIS
`
`DUFFEL BAG AND SLIDE IT OVER.
`
`SO EVEN THOUGH THE INCISION WAS ON THE FRONT, THEY
`
`WERE KIND OF GOING TO THE SIDE AND GOING BEHIND THE DUFFEL
`
`BAG, MOVING IT OVER.
`
`SO RETRO JUST MEANS BEHIND. PERITONEAL MEANS THAT
`
`DUFFEL SAC. WE CALL IT THE "PERITONEUM."
`
`WHAT MR. BOYD IS SAYING IS VERY INTERESTING,
`
`BECAUSE THAT IS AN ANTERIOR RETROPERITONEAL APPROACH.
`
`ANTERIOR MEANS WE MADE THE INCISION IN THE FRONT, AND YET WE
`
`REACHED AROUND, MOVED THE DUFFEL BAG OVER, SO BEHIND -- WE
`
`MOVED IT TO THE SIDE, AND NOW WE DO THE SURGERY.
`
`THIS IS THE FIRST TIME HE'S EVER SEEN A LATERAL
`
`RETROPERITONEAL, WHERE YOU DON'T EVEN HAVE TO MOVE THE
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
`
`Page 6
`
`

`

` 196
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`PERITONEUM SAC. LEAVE IT ALONE. BUT YOU'RE SO FAR BEHIND
`
`IT, YOU JUST GO STRAIGHT IN.
`
`Q
`
`SO I UNDERSTAND, MAYBE I DON'T HAVE -- LET ME TRY THIS,
`
`DR. MICHELSON. WE DON'T HAVE A MODEL HERE. IF WE LOOK AT
`
`THE FRONT OF THE SPINE, RIGHT?
`
`A
`
`Q
`
`YES.
`
`OR ACTUALLY, LET'S LOOK AT THE SIDE OF THE SPINE.
`
`OKAY. WITH ME?
`
`A
`
`Q
`
`UH-HUH.
`
`WE'RE LOOKING AT THE SIDE HERE. SO THERE IS THE FRONT,
`
`ANTERIOR, THIS IS THE BACK. WE HAVE THESE BONY PROTRUSIONS
`
`OUT HERE, RIGHT?
`
`A
`
`Q
`
`YES.
`
`THE PERITONEAL SAC, JUST SO WE'RE CLEAR, DOES IT ATTACH
`
`ALONG THE SIDE LIKE THIS?
`
`A
`
`Q
`
`A
`
`Q
`
`A
`
`NO. IT LAYS UP AGAINST THE FRONT.
`
`THIS IS THE FRONT OF THE SPINE?
`
`WELL, THE FRONT WAS TOWARDS YOU, YOU SAID.
`
`RIGHT.
`
`YES. SO THE SAC DOESN'T GO ONTO THE VERTEBRAL BODIES.
`
`IT JUST LAYS UP. IT'S SELF-CONTAINED.
`
`Q
`
`SO THE IDEA IS TO MOVE THE SAC OUT OF THE WAY AS YOU
`
`ARE APPROACHING INTO THE SPINE?
`
`A
`
`WHEN WE DID AN ANTERIOR, FROM THE FRONT,
`
`RETROPERITONEAL DISSECTION TO GET THE SPINE, WHAT WE WERE
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
`
`Page 7
`
`

`

`08-CV-1512-MMA
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE SOUTHERN DISTRICT OF CALIFORNIA
`HONORABLE MICHAEL M. ANELLO, DISTRICT JUDGE
`MEDTRONIC SOFAMOR DANEK, USA, .
`ET AL., .CASE NO. 08-CV-1512-MMA
`.
`PLAINTIFF,
`.
`.
`V.
`. AUGUST 31, 2011
`.
`NUVASIVE, INC.,
`. WEDNESDAY, 1:30 P.M.
`.
`DEFENDANT.
`. TRIAL - DAY TWO
`. . . . . . . . . . . . . . . . . ..
`
`REPORTER'S TRANSCRIPT OF PROCEEDINGS
`
`APPEARANCES:
`FOR THE PLAINTIFF:
`
`FOR THE DEFENDANTS:
`
`LUKE L. DAUCHOT, ESQ.
`NIMALKA WICKRAMASEKERA, ESQ.
`SHARRE LOTFOLLAHI, ESQ.
`ALEXANDER F. MACKINNON, ESQ.
`MICHAEL DOBSZEWICZ, ESQ.
`KIRKLAND & ELLIS, LLP
`JEFF SCHWARTZ, ESQ.
`DEWEY & LEBOEUF
`
`FRANK SCHERKENBACH, ESQ.
`JOHN M. FARRELL, ESQ.
`TODD G. MILLER, ESQ.
`JONATHAN J. LAMBERSON, ESQ.
`NEIL WARREN, ESQ.
`KEELEY I. VEGA, ESQ.
`
`COURT REPORTER:
`
`JULIET Y. EICHENLAUB, CSR
`USDC CLERK'S OFFICE
`880 FRONT STREET, ROOM 4290
`SAN DIEGO, CALIFORNIA 92101
`JULIET_EICHENLAUB@CASD.USCOURTS.GOV
`REPORTED BY STENOTYPE, TRANSCRIBED BY COMPUTER
`
`310
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 8
`
`

`

`08-CV-1512-MMA
`
`INDEX - 08-CV-1512
`MEDTRONIC V. NUVASIVE, 8/31/11
`
`WITNESSES:
`
` DIRECT CROSS REDIRECT RECROSS
`
`DAVID ALAN SHARP
`PATRICK MILES
`
` 312
` 401
`
` 336
` 435
`
`361
`
`VIDEOTAPE DEPOSITION OF DR. SMITH
`VIDEOTAPE DEPOSITION OF DR. FOLEY
`READING OF DEPOSITION TESTIMONY OF DR. FOLEY
`
`PAGE 365
` PAGE 382
`PAGE 391
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`311
`
`Page 9
`
`

`

`08-CV-1512-MMA
`
`DOCUMENT ALSO LISTS DR. BERTINELLI, WHO WAS A SURGEON IN EUROPE
`THAT WAS BEING WORKED WITH AT THE TIME AS WELL.
`Q.
`DID YOU PERSONALLY WORK WITH DR. BERTINELLI?
`A.
`I KNEW, DR. BERTINELLI, YES.
`Q.
`NOW, WERE THE LONG METAL CAGES -- AND I BELIEVE YOU
`TESTIFIED THAT THE LONG METAL CAGES WERE NOT COMMERCIALIZED IN
`THE UNITED STATES. WERE THEY EVER COMMERCIALIZED ANYWHERE?
`A.
`YES. WE WERE ABLE TO GET THE LONGER IMPLANTS
`AVAILABLE IN THE MARKET IN EUROPE, I BELIEVE, IN THE FALL OF
`1998 OR MAYBE EARLY '99.
`Q.
`AND WHAT SIZES WERE COMMERCIALIZED?
`A.
`THE LENGTHS WOULD HAVE BEEN 35 AND 40 MILLIMETERS IN
`LENGTH.
`NOW, MR. SHARP, WHAT HAPPENED WITH THE LATERAL
`Q.
`INSTRUMENT PROJECT?
`A.
`SURE. AGAIN, IN LATE 2000, EARLY 2001, I TRANSFERRED
`THE PROJECT TO DIANA PARAMOUR, WHO IS ANOTHER MARKETING PERSON
`WITHIN THE GROUP. SHE WORKED ON THE FINAL COMMERCIALIZATION
`AND LAUNCHED THAT PROJECT IN THE FALL OF 2001. THERE WAS AN
`ADDITIONAL PROJECT GOING ON LOOKING AT LATERAL PLACEMENT, A
`PROJECT CALLED ELIF, THAT WAS BEING WORKED ON WITH DR. KEVIN
`FOLEY.
`YOU USED THE TERM "ELIF." WHAT DID THE TERM "ELIF"
`Q.
`STAND FOR?
`A.
`ELIF STANDS FOR EXTREME LATERAL INTERBODY FUSION.
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`329
`
`Page 10
`
`

`

`08-CV-1512-MMA
`
`BUT THE TRUTH, SO HELP YOU GOD?
`THE WITNESS: I DO.
`THE CLERK: PLEASE STATE YOUR FULL NAME FOR THE
`RECORD AND SPELL IT PLEASE.
`THE WITNESS: PATRICK MILES. LAST NAME, M-I-L-E-S.
`FIRST NAME, P-A-T-R-I-C-K.
`THE COURT: THANKS, MR. MILES. GO AHEAD AND HAVE A
`SEAT. MR. DAUCHOT?
`
`DIRECT EXAMINATION
`
`BY MR. DAUCHOT:
`Q.
`THANK YOU, YOUR HONOR.
`MR. MILES, GOOD AFTERNOON.
`GOOD AFTERNOON.
`THIS IS THE FIRST TIME WE MET?
`FIRST TIME YOU AND I MET?
`YES.
`I BELIEVE SO.
`YOU'VE BEEN DEPOSED IN THIS CASE BEFORE, THOUGH?
`I HAVE.
`I THINK MY COLLEAGUE, MS. WICKRAMASEKERA, DID THAT.
`DO YOU REMEMBER THAT?
`I DO.
`YOU BEGAN WORKING FOR NUVASIVE IN JANUARY 2001; AM I
`
`A.
`Q.
`A.
`Q.
`A.
`Q.
`A.
`Q.
`
`A.
`Q.
`RIGHT?
`A.
`
`YES.
`
`401
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 11
`
`

`

`08-CV-1512-MMA
`
`AND YOU -- THAT'S WHEN MR. VALENTINE ALSO JOINED THE
`Q.
`COMPANY; CORRECT?
`A.
`IT IS.
`Q.
`AND YOU LEFT MEDTRONIC SOFAMOR DANEK IN APRIL OF
`2000; IS THAT ABOUT RIGHT?
`A.
`I BELIEVE SO; YEAH, LEFT MEDTRONIC.
`Q.
`AND WHEN YOU LEFT MEDTRONIC SOFAMOR DANEK, YOUR
`PRINCIPAL AREA OF WORK WAS WHAT WE CALL MINIMALLY INVASIVE
`SPINE SURGERY DEVICES; AM I RIGHT?
`A.
`YES; IT WAS THAT AND CERVICAL SPINE SURGERY.
`Q.
`AND WHEN YOU WORKED ON MINIMALLY INVASIVE SPINE
`SURGERY DEVICES FOR SOFAMOR DANEK, YOU DID SO WITH DR. FOLEY;
`AM I CORRECT?
`A.
`YES, I DID.
`Q.
`AND YOU ALSO WORKED WITH MR. MELKENT; AM I RIGHT?
`A.
`NOT DIRECTLY.
`Q.
`INDIRECTLY?
`A.
`INDIRECTLY, YES.
`Q.
`INDIRECTLY. ALL RIGHT.
`AND YOU ALSO WORKED WITH MR. BOYD?
`NOT COMMONLY.
`A.
`UNCOMMONLY?
`Q.
`IF THAT'S THE WAY YOU'D LIKE TO CHARACTERIZE IT. I
`A.
`DIDN'T SEE HIM VERY OFTEN.
`Q.
`OKAY.
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`402
`
`Page 12
`
`

`

`08-CV-1512-MMA
`
`YES.
`YOU SEE THE REFERENCE TO ELIF?
`I DO.
`YOU SEE THE REFERENCE TO EXTREME LATERAL INTERBODY
`
`A.
`Q.
`A.
`Q.
`FUSION?
`I DO.
`A.
`IT'S STILL YOUR TESTIMONY YOU CAME UP WITH THE TERM
`Q.
`EXTREME LATERAL INTERBODY FUSION AFTER YOU JOINED NUVASIVE IN
`2001?
`THAT IS MY TESTIMONY.
`A.
`NOW, EXTREME LATERAL INTERBODY FUSION REFERS TO A
`Q.
`MEDICAL PROCEDURE; CORRECT?
`A.
`IT IS THE BRANDING THAT IS REFLECTED IN A MEDICAL
`PROCEDURE.
`Q.
`WILL YOU AGREE WITH ME THAT BEFORE YOU BRAND YOU NEED
`A PROCEDURE? THE PROCEDURE COMES FIRST; THE BRANDING COMES
`NEXT?
`A.
`Q.
`
`I'LL AGREE WITH THAT.
`YOU'LL AGREE WITH THAT. ALL RIGHT.
`IT'S A FACT, IS IT NOT, THAT NUVASIVE TRADEMARKED THE
`NAME XLIF ON JANUARY 31, 2001, MR. MILES?
`A.
`THAT DATE, I DON'T SPECIFICALLY RECALL.
`Q.
`YOU DON'T SPECIFICALLY RECALL. CAN YOU PUT THAT UP?
`THAT IS A TRADEMARK APPLICATION; DO YOU SEE THAT, MR. MILES?
`A.
`I SEE THE SHEET, YES.
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`434
`
`Page 13
`
`

`

`08-CV-1512-MMA
`
`ALL RIGHT. DAVE, CAN YOU BLOW IT UP? YOU SEE THAT
`Q.
`THE FILING DATE FOR THE APPLICATION IS JANUARY 31, 2001,
`MR. MILES?
`A.
`I DO.
`Q.
`AND DO YOU SEE THAT THE NAME BEING APPLIED FOR IS --
`LOOK AT THE TOP. WHAT DOES THAT SAY?
`A.
`IT'S X-L-I-F.
`Q.
`XLIF, STANDING FOR EXTREME LATERAL INTERBODY FUSION;
`AM I CORRECT, MR. MILES?
`A.
`THAT IS CORRECT.
`THE COURT: I'M NOT SURE WE IDENTIFIED THAT FOR THE
`RECORD. IS IT EXHIBIT PX2537?
`MR. DAUCHOT: IT IS, YOUR HONOR. THANK YOU FOR
`REMINDING ME.
`ALL RIGHT. MR. MILES, I HAVE NO FURTHER QUESTIONS.
`THE COURT: MR. SCHERKENBACH.
`MR. SCHERKENBACH: THANK YOU, YOUR HONOR.
`MR. MILES, DO ME A FAVOR AND SEE IF YOU CAN PULL THAT
`MICROPHONE A LITTLE CLOSER TO YOU.
`THE COURT: UNFORTUNATELY, THE CHAIR DOESN'T --
`THE WITNESS: FAIR ENOUGH. GOT IT.
`CROSS-EXAMINATION
`
`BY MR. SCHERKENBACH:
`Q.
`FIRST OF ALL, I DON'T BELIEVE YOU WERE ASKED TO TELL
`THE JURY WHAT YOUR TITLE IS AT NUVASIVE AND WHAT YOU DO.
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`435
`
`Page 14
`
`

`

` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
` 443
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE SOUTHERN DISTRICT OF CALIFORNIA
`
`HONORABLE MICHAEL M. ANELLO, DISTRICT JUDGE
`
`_____________________________
`)
`MEDTRONIC SOFAMOR DANEK, USA ) CASE NO. 08 CV 1512-MMA
`ET AL.,
`)
`)
`)
`)
`) SEPTEMBER 1, 2011
`)
`) THURSDAY, 9:00 AM
`)
`) TRIAL - DAY THREE
`DEFENDANT.
`_____________________________)
`
`PLAINTIFF,
`
`VS.
`
`NUVASIVE, INC.,
`
`
`
`
`
`REPORTER'S TRANSCRIPT OF PROCEEDINGS
`
`APPEARANCES:
`
`FOR THE PLAINTIFF:
`
`
`
`
`FOR THE DEFENDANT:
`
`
`
`LUKE L. DAUCHOT, ESQ.
`NIMALKA WICKRAMASEKERA, ESQ.
`SHARRE LOTFOLLAHI, ESQ.
`ALEXANDER F. MACKINNON, ESQ.
`MICHAEL DOBSZEWICZ, ESQ.
`KIRKLAND & ELLIS, LLP
`
`JEFF SCHWARTZ, ESQ.
`DEWEY & LEBOEUF
`
`FRANK SCHERKENBACH, ESQ.
`TODD G. MILLER, ESQ.
`JONATHAN J. LAMBERSON, ESQ.
`NEIL WARREN, ESQ.
`KEELEY I. VEGA, ESQ.
`FISH & RICHARDSON, P.C.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 15
`
`

`

` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`INDEX - 08 CV 1512
`
`MEDTRONIC V. NUVASIVE, 8/31/11
`
`
`
`WITNESSES:
`
`PATRICK MILES
`
`CROSS BY MR. SCHERKENBACH
`
`REDIRECT BY MR. DAUCHOT
`
`RECROSS BY MR. SCHERKENBACH
`
`
`
`ALEXIS V. LUKIANOV
`
`DIRECT BY MR. DAUCHOT
`
`CROSS BY MR. SCHERKENBACH
`
` 444
`
`PAGE:
`
` 445
`
` 472
`
` 496
`
` 501
`
` 548
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 16
`
`

`

` 473
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`WAS WORKING AT THE LABS AT SOFAMOR DANEK. HAVE YOU HEARD OF
`
`THAT TESTIMONY?
`
`A
`
`Q
`
`A
`
`I'VE HEARD OF THE TESTIMONY AND IT'S WRONG.
`
`BUT DR. FOLEY IS NOT BEING TRUTHFUL?
`
`IT'S NOT THAT HE'S NOT BEING TRUTHFUL. HE POORLY
`
`RECOLLECTIONS THE EXPERIENCE. AND E STOOD FOR ENDOSCOPIC.
`
`Q
`
`NOW YOU REMEMBER WE LOOKED AT A DOCUMENT YESTERDAY
`
`DATED JULY OF 2000, DO REMEMBER THAT? THE MEMO?
`
`A
`
`Q
`
`A
`
`Q
`
`A
`
`Q
`
`A
`
`Q
`
`I DO.
`
`AND THAT WAS DATED JULY 2000?
`
`ARE YOU ASKING ME?
`
`YES, SIR.
`
`I BELIEVE IT WAS JULY 2000.
`
`THREE MONTHS AFTER YOU LEFT MEDTRONIC, CORRECT?
`
`YEAH. I LEFT IN APRIL, I BELIEVE.
`
`RIGHT. AND THAT DOCUMENT SAID ELIF STANDS FOR EXTREME
`
`LATERAL INTERBODY FUSION, DO YOU REMEMBER SEEING THAT IN THE
`
`DOCUMENT?
`
`A
`
`Q
`
`I DO. IT DOES NOT MEAN IT'S ACCURATE.
`
`I SEE. NOW DR. FOLEY ALSO TESTIFIED THAT HE WAS
`
`WORKING ON AN EXTREME LATERAL INTERBODY FUSION PROCEDURE IN
`
`THE LAB AT SOFAMOR DANEK. DO YOU KNOW OF THAT TESTIMONY?
`
`A
`
`I WORKED WITH DR. FOLEY ON PROCEDURES AND I'M AWARE
`
`THAT WE WERE WORKING ON ELIF, ENDOSCOPIC LATERAL INTERBODY
`
`FUSION.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 17
`
`

`

` 474
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. DAUCHOT: YOUR HONOR, IS IT OKAY IF I QUESTION
`
`A LITTLE BIT FROM HERE?
`
`THE COURT: YES.
`
`BY MR. DAUCHOT:
`
`Q
`
`NOW DR. FOLEY TESTIFIED THAT HIS EXTREME LATERAL
`
`INTERBODY FUSION WORK TESTING, HE WAS TRYING TO APPROACH THE
`
`VERTEBRA, THE DISK SPACE FROM THE ANTERIOR PORTION SO THE
`
`FRONT PORTION OF THE SPINE. JUST ABOVE THE, OR JUST AHEAD,
`
`ANTERIOR TO THE BONES BACK HERE, LIKE THIS. AND I THINK HE
`
`MENTIONED A 70 PROCEDURE. ARE YOU FAMILIAR WITH DR. FOLEY'S
`
`70 PROCEDURE?
`
`A
`
`Q
`
`A
`
`UMM --
`
`WHILE HE WAS AT MEDTRONIC?
`
`NO. AND YOU HAD HAVE TAKEN OUT A VERTEBRAL ARTERY FROM
`
`THERE.
`
`Q
`
`SO IT'S YOUR TESTIMONY EVEN THOUGH DR. FOLEY IS SAYING
`
`HE WAS APPROACHING AND TESTING IN LABS AN APPROACH TO THE
`
`DISC SPACE AT A 70-DEGREE ANGLE LIKE THIS, THEN HIS
`
`TESTIMONY WAS INCORRECT?
`
`A
`
`I'M TELLING YOU I WAS WITH DR. FOLEY IN A LAB WHERE THE
`
`PATIENT WAS ON THEIR BELLY AND WE WERE PROBABLY AT A 45 TO
`
`60 DEGREE OFF MIDLINE. IT LOOKED NOTHING LIKE A LATERAL
`
`APPROACH.
`
`Q
`
`A
`
`SO HE WAS 60 OFF MID LINE?
`
`60 TO 75.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 18
`
`

`

` 475
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Q
`
`A
`
`Q
`
`SIXTY TO 75, LIKE THE XLIF 60?
`
`SIMILAR.
`
`SIMILAR. SIMILAR TO THE XLIF 60 THAT YOU SAID YOU
`
`STARTED WORKING ON AT NUVASIVE, AM I CORRECT?
`
`A
`
`Q
`
`THAT'S CORRECT.
`
`THAT'S CORRECT. NOW YOU TESTIFIED THAT IN -- YESTERDAY
`
`WE SHOWED A PRESS RELEASE, NOVEMBER 2001, DO YOU REMEMBER
`
`THAT?
`
`A
`
`Q
`
`I DO.
`
`AND YOUR TESTIMONY YESTERDAY WAS THAT THE PRESS RELEASE
`
`WAS ABOUT XLIF 60, RIGHT? THE NOVEMBER 2001 PRESS RELEASE?
`
`A
`
`YEAH. THAT WAS MY EXPECTATION BASED UPON THE TIMING OF
`
`WHEN WE STARTED DOING LATERAL APPROACH SURGERY. AND.
`
`Q
`
`AND YOU SAID THAT THE NOVEMBER 2001, THE XLIF
`
`PROCEDURE, THE XLIF 60 WAS NOT SAFE AND REPRODUCIBLE. DO I
`
`HAVE THAT RIGHT?
`
`A
`
`Q
`
`THAT'S WHY DR. FOLEY NEVER COMMERCIALIZED IT.
`
`MY QUESTION WAS, WHEN YOU CAME OUT WITH THE
`
`NOVEMBER 2001 PRESS RELEASE AT NUVASIVE ABOUT THE XLIF
`
`PROCEDURE?
`
`A
`
`WHAT I SAID WAS IT WAS NOT SAFE IN THE HANDS OF THE
`
`MANY.
`
`THE COURT: WE'RE GOING TO TRY TO MAKE OUR LIVES
`
`EASIER AND ALSO MAKE OUR COURT REPORTER'S LIFE EASIER BY
`
`ALLOWING HIM TO COMPLETELY FINISH HIS QUESTIONS BEFORE YOU
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 19
`
`

`

` 50
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`OF TWO WEEKS, YOU'LL ALL BE EXPERTS, I THINK. ALL RIGHT.
`
`THE 973 PATENT, THAT'S THE FIRST PATENT AT ISSUE
`
`HERE. THE UNITED STATES PATENT AND TRADEMARK OFFICE AWARDED
`
`A PATENT TO AN INVENTOR CALLED DR. GARY MICHELSON.
`
`DR. MICHELSON A WITNESS FROM WHOM YOU'LL HERE.
`
`DR. MICHELSON IS A PIONEER IN SPINE SURGERY. HE LITERALLY
`
`CHANGED THE FACE OF SPINE SURGERY. HE HAS A TOTAL OF 250
`
`PATENTS AWARDED IN HIS NAME, AND HE WAS INDUCTED INTO THE
`
`NATIONAL INVENTORS HALL OF FAME FOR WHAT HE DID IN SPINAL
`
`SURGERY.
`
`WHAT'S THE TRANSLATERAL IMPLANT ABOUT? THE
`
`TRANSLATERAL IMPLANT IS AN IMPLANT, OKAY, THAT IS
`
`DIMENSIONED SO THAT IT CAN FIT THE ENTIRE WIDTH OF THE
`
`VERTEBRAE. SO WHEN I'M TALKING ABOUT THE WIDTH, FROM HERE
`
`TO THE OTHER SIDE. OKAY?
`
`AND IN ORDER TO -- GIVEN THIS DIMENSION, IT IS
`
`INSERTED TRANSLATERALLY. ALL RIGHT. IT'S AN ESPECIALLY
`
`DIMENSIONED IMPLANT, THAT GIVEN ITS DIMENSIONS, THEY ARE
`
`MADE AVAILABLE BY VIRTUE OF ITS TRANSLATERAL LOCATION ALLOWS
`
`FOR BETTER FUSION, OKAY, LESS SURGICAL TRAUMA, AND BETTER
`
`RESULTS, AND MORE STABILITY. AND WE'LL GET INTO THAT. IT'S
`
`A TRANSLATERAL IMPLANT.
`
`NEXT SLIDE, PLEASE.
`
`NOW, DR. MICHELSON RECEIVED CLAIMS ON A
`
`TRANSLATERAL IMPLANT, LIKE I MENTIONED. AND HERE ARE TWO
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 20
`
`

`

` 51
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`EXAMPLES OF THE CLAIMS. THERE ARE MORE CLAIMS BEING
`
`INSERTED. I'M TALKING ABOUT A TRANSLATERAL SPINAL IMPLANT
`
`WITH A NUMBER OF DIMENSIONAL PROPERTIES. OKAY?
`
`AND, FOR EXAMPLE, SOME OF THE CLAIMS HAVE SPECIFIC
`
`LENGTHS. IT'S REQUIRED. AND THEN THERE'S ANOTHER ONE ABOUT
`
`HAVING A RECTANGULAR SHAPE, WHICH HELPS WITH STABILITY
`
`ISSUES, AND WE'LL GET INTO THAT.
`
`BUT THERE ARE A NUMBER OF CLAIMS. THESE ARE JUST
`
`A COUPLE OF EXAMPLES.
`
`NOW, WHY ARE WE HERE?
`
`IN 2003, NUVASIVE LAUNCHED WHAT IS CALLED ITS
`
`"X-LIFT PROCEDURE" WITH A SPINAL IMPLANT -- LINE OF SPINAL
`
`IMPLANTS CALLED "COROENT XL." ALL RIGHT?
`
`NEXT SLIDE.
`
`TO THE RIGHT WE HAVE NUVASIVE'S BROCHURE ABOUT ITS
`
`IMPLANT. THAT IMPLANT IS A TRANSLATERAL IMPLANT. IT WAS
`
`DESIGNED FOR THE UNIQUE EXTREME LATERAL APPROACH.
`
`IF YOU LOOK AT THE MICHELSON PATENT AND THE
`
`DESCRIPTION IN THE MICHELSON PATENT, THEREFORE, THERE EXISTS
`
`A NEED FOR SPINAL FUSION IMPLANT THAT IS INSERTED FROM THE
`
`TRANSLATERAL APPROACH TO THE SPINE.
`
`NEXT SLIDE.
`
`"NUVASIVE'S COROENT IMPLANT PROVIDES A LARGE
`
`ANATOMICAL SHAPE FOR MAXIMUM SURFACE AREA ENGAGEMENT AND
`
`STRUCTURAL STABILITY BY THE VIRTUE OF ITS TRANSLATERAL
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 21
`
`

`

` 54
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`ATTENDED THE PRESENTATION OF THE TECHNOLOGY. THIS IS GOING
`
`BACK IN JANUARY OF '94.
`
`WHAT DID THEY SAY THEN ABOUT THE TECHNOLOGY?
`
`MICHELSON TECHNOLOGY EXPANDS THE PRODUCT OFFERING THAT WE
`
`CURRENTLY HAVE AND GIVES THE COMPANY ACCESS TO A BROAD RANGE
`
`OF TECHNOLOGY, FROM ANTERIOR, FROM THE POSTERIOR, AND THE
`
`LATERAL, AMONG OTHER THINGS.
`
`AND REMEMBER AT THIS POINT IN TIME, THE INTERBODY
`
`FUSION APPROACHES WERE BEING ATTACKED FROM THE FRONT OR THE
`
`BACK. WHAT THEY NOTICED, COMPARED TO THE RELATIVELY LIMITED
`
`CURRENT OFFERING OF INTERBODY FUSION DEVICES IN THE SPINAL
`
`IMPLANT MARKETPLACE, SOFAMOR DANEK HAS THE OPPORTUNITY TO
`
`DEVELOP A FULL LINE OF INTERBODY FUSION TO ADDRESS A
`
`COMPLICATED RANGE OF SPINAL CONDITIONS.
`
`AND THERE ARE OTHER DOCUMENTS LIKE THAT, THAT
`
`YOU'LL SEE AT TRIAL.
`
`SO WHAT'S THE POINT? THE POINT IS THAT BACK THEN,
`
`INDIVIDUALS SUCH AS MR. LUKIANOV AND OTHERS, BECAUSE THE
`
`DECISION WAS MADE TO LICENSE THE MICHELSON TECHNOLOGY,
`
`BELIEVED THAT THIS TECHNOLOGY WAS INNOVATIVE, CREATIVE. AND
`
`YOU'LL HEAR TESTIMONY TO THIS EFFECT.
`
`TODAY, IT'S A DIFFERENT STORY. TODAY THE STORY
`
`IS, NOW THAT NUVASIVE USES IT, IS THAT THE PATENT WAS A
`
`MISTAKE. THE PATENT SHOULD NOT HAVE BEEN GRANTED BY THE
`
`PATENT OFFICE.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 22
`
`

`

`IN THE UNITED STATES DISTRICT COURT
`FOR THE SOUTHERN DISTRICT OF CALIFORNIA
`HONORABLE MICHAEL M. ANELLO, DISTRICT JUDGE
`MEDTRONIC SOFAMOR DANEK, USA, .
`ET AL., .CASE NO. 08-CV-1512-MMA
`.
`PLAINTIFF,
`.
`.
`V.
`. SEPTEMBER 1, 2011
`.
`NUVASIVE, INC.,
`. THURSDAY, 1:30 P.M.
`.
`DEFENDANT.
`. TRIAL - DAY THREE
`. . . . . . . . . . . . . . . . . ..
`
`REPORTER'S TRANSCRIPT OF PROCEEDINGS
`
`APPEARANCES:
`FOR THE PLAINTIFF:
`
`FOR THE DEFENDANTS:
`
`LUKE L. DAUCHOT, ESQ.
`NIMALKA WICKRAMASEKERA, ESQ.
`SHARRE LOTFOLLAHI, ESQ.
`ALEXANDER F. MACKINNON, ESQ.
`MICHAEL DOBSZEWICZ, ESQ.
`KIRKLAND & ELLIS, LLP
`JEFF SCHWARTZ, ESQ.
`DEWEY & LEBOEUF
`
`FRANK SCHERKENBACH, ESQ.
`JOHN M. FARRELL, ESQ.
`TODD G. MILLER, ESQ.
`JONATHAN J. LAMBERSON, ESQ.
`NEIL WARREN, ESQ.
`KEELEY I. VEGA, ESQ.
`
`COURT REPORTER:
`
`JULIET Y. EICHENLAUB, CSR
`USDC CLERK'S OFFICE
`880 FRONT STREET, ROOM 4290
`SAN DIEGO, CALIFORNIA 92101
`JULIET_EICHENLAUB@CASD.USCOURTS.GOV
`REPORTED BY STENOTYPE, TRANSCRIBED BY COMPUTER
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 23
`
`

`

`08-CV-1512
`
`INDEX - 08-CV-1512
`MEDTRONIC V. NUVASIVE, 9/1/11
`
`WITNESSES:
`
` DIRECT CROSS REDIRECT RECROSS
`
`ALEXIS LUKIANOV
`ANTHONY MELKENT
`DR. BARTON SACHS
`
` 592
` 652
`
`579
` 568
` 625 648
`
` 650
`
`
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`567
`
`Page 24
`
`

`

`08-CV-1512
`
`WHERE EVERYONE ELSE HAD FAILED TO DO SO. AND SO FOR ME IT WAS
`A VERY INTERESTING CHALLENGE, AND IT'S ONE THAT I JUMPED ON.
`Q.
`AT THE TIME YOU GOT THE CALL FROM THE RECRUITER, WERE
`YOU WORKING AT WARSAW ORTHOPEDIC?
`A.
`NO.
`Q.
`WERE YOU WORKING AT SOFAMOR DANEK?
`A.
`NO, I LEFT A FEW YEARS BEFORE.
`Q.
`ALL RIGHT.
`AT THE TIME YOU JOINED NUVASIVE, '99, WHERE WAS THE
`COMPANY LOCATED?
`A.
`IT WAS LOCATED IN SCRIPPS RANCH IN SAN DIEGO.
`Q.
`HOW MANY EMPLOYEES DID IT HAVE?
`A.
`17, 18, SOMETHING LIKE THAT.
`Q.
`SO YOU WERE LIKE NUMBER 18 OR NUMBER 19?
`A.
`YES.
`Q.
`HOW MANY EMPLOYEES TODAY?
`A.
`TOTAL FAMILY SIZE, OR WE CALL IT THE NUVA FAMILY, IS
`OVER 1100 PEOPLE, GLOBALLY.
`Q.
`AND AT THE TIME YOU JOINED, IT HAD THE INS NERVE
`SURVEILLANCE TECHNOLOGY?
`A.
`YES.
`Q.
`MOVING FORWARD IN TIME, FROM WHEN YOU JOINED THE
`COMPANY IN '99 TO WHEN THE COMPANY ANNOUNCED, RELEASED XLIF,
`XLIF 90, AS WE HAVE HEARD IT CALLED. WHAT'S THAT PERIOD OF
`TIME? HOW MANY YEARS IS THAT?
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`573
`
`Page 25
`
`

`

`08-CV-1512
`
`WELL, FROM '99 TO 2003, WHEN WE DID THE FULL LAUNCH
`A.
`AT NASS, NORTH AMERICAN SPINE SOCIETY MEETING, ONE OF THE MOST
`IMPORTANT SPINE MEETINGS THAT SURGEONS ATTEND. IT WAS ACTUALLY
`HERE IN SAN DIEGO. IT WAS USUALLY EXCITING FOR US, BUT IT WAS
`ABOUT FOUR YEARS.
`Q.
`AND WHEN WAS -- MAXCESS WAS INTRODUCED IN LATE 2003;
`IS THAT RIGHT?
`A.
`WELL, YES.
`Q.
`SO THAT WOULD HAVE BEEN ABOUT A FOUR-YEAR PERIOD AS
`WELL TO DEVELOP MAXCESS?
`A.
`THAT'S RIGHT.
`Q.
`AND COROENT?
`A.
`COROENT.
`Q.
`THAT CAME LATER STILL, DIDN'T IT?
`A.
`COROENT WAS 2004.
`Q.
`BETWEEN THE TIME YOU LEFT SOFAMOR DANEK, AT THE END
`OF '95, AND THE DAY MEDTRONICS SUED YOU IN THIS LAWSUIT IN
`2008, DID ANYONE FROM SOFAMOR DANEK OR MEDTRONIC SOFAMOR DANEK,
`OR MEDTRONIC, EVER SUGGEST TO YOU THAT YOU OR YOUR COMPANY HAD
`MISAPPROPRIATED ANYTHING FROM THEM?
`A.
`NO.
`Q.
`IN FACT, AFTER YOU LEFT THE MEDTRONIC COMPANIES, DID
`THEY ENGAGE YOU AS A CONSULTANT?
`A.
`YES.
`Q.
`TELL US ABOUT THAT.
`
`1 2 3 4 5 6 7 8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`574
`
`Page 26
`
`

`

` 61
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`TREMENDOUS REPUTATION.
`
`DR. FOLEY WORKED WITH MEDTRONICS SOFAMOR DANEK ON
`
`MINIMALLY INVASIVE TECHNIQUES. REMEMBER THE RETRACTOR THAT
`
`I TALKED ABOUT AND HOW TO APPROACH THESE THINGS SO YOU DON'T
`
`HAVE TO CUT A PATIENT WIDE OPEN TO GET TO THE SPACE?
`
`MINIMALLY INVASIVE STUFF, IMPORTANT STUFF.
`
`THE MINIMALLY INVASIVE PROCEDURES THAT DR. FOLEY
`
`WAS WORKING ON, HE WAS WORKING WITH SOFAMOR DANEK EMPLOYEES,
`
`INCLUDING AN INDIVIDUAL NAMED PATRICK MILES. PATRICK MILES,
`
`WHICH YOU'LL SEE IN A SECOND, WAS AMONG THOSE WHO LEFT
`
`SOFAMOR DANEK.
`
`HE JOINED NUVASIVE IN 2001, AND TODAY HE IS
`
`PRESIDENT OF THE AMERICAS. YOU WILL HEAR EVIDENCE THAT
`
`DR. MILES WORKED ON PRECISELY THE SAME SORT OF TECHNOLOGY
`
`THAT HE WAS WORKING ON BACK WHEN HE WAS AT SOFAMOR DANEK.
`
`SO WE HAVE ALL OF THIS WORK GOING ON.
`
`NEXT SLIDE. THANKS, DAVE.
`
`IN JULY OF 1999, MR. LUKIANOV JOINS NUVASIVE. HE
`
`HAD LEFT SOFAMOR DANEK IN 1995. THE CHARGE THAT MR.
`
`LUKIANOV HAD WAS TO TURN THE COMPANY AROUND. IT WAS NOT
`
`DOING WELL. AND MR. LUKIANOV DID DO THAT. HE WAS
`
`EXTRAORDINARILY SUCCESSFUL AT IT.
`
`WHAT DID HE DO?
`
`NEXT SLIDE.
`
`WELL, IN JANUARY OF 2000, MR. MILES, OUR MINIMALLY
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 27
`
`

`

` 62
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`INVASIVE PERSON WHO WORKED WITH DR. FOLEY, LEFT.
`
`IN 2000, MR. VALENTINE, THE PERSON WHO HANDLED A
`
`NUMBER OF THINGS IN OUR WHAT WE CALL INTERBODY GROUP AT
`
`SOFAMOR DANEK -- IT WASN'T JUST LATERAL, BUT INTERBODY
`
`AGAIN, DEALING WITH THIS AREA, LEFT.
`
`AND DR. FOLEY WAS ASKED BY MR. LUKIANOV TO START
`
`CONSULTING FOR NUVASIVE. IN FACT, MR. LUKIANOV INVITED
`
`DR. FOLEY TO JOIN THE NUVASIVE BOARD OF DIRECTORS. THAT'S
`
`HOW HIGHLY HE THOUGHT OF DR. FOLEY. AND DR. FOLEY DID NOT
`
`DO THAT.
`
`NEXT SLIDE.
`
`IN 2001, JANUARY, MR. VALENTINE AND MR. MILES
`
`JOINED NUVASIVE.
`
`NEXT SLIDE, PLEASE.
`
`IN 2001 TO 2003 -- IT'S ACTUALLY A SHORTER TIME
`
`FRAME, AND YOU'LL HEAR EVIDENCE WHY IT IS A SHORTER TIME
`
`FRAME -- NUVASIVE COMES OUT, LAUNCHES A MINIMALLY INVASIVE
`
`PROCEDURE WITH MAXCESS RETRACTORS FOR MINIMALLY INVASIVE
`
`WORK, THE RETRACTORS I TALKED ABOUT, A TRANSLATERAL SURGICAL
`
`APPROACH, THE ONE THAT DR. MICHELSON HAD NOTED IN HIS
`
`PATENT, THE COROENT PRODUCT, THE PRODUCT THAT TELLS THE SAME
`
`THINGS THAT DR. MICHELSON PATENT DID, AND A PRODUCT CALLED
`
`NEURO VISION, A WAY OF NERVE MONITORING AS YOU'RE COMING IN.
`
`NEXT SLIDE, PLEASE.
`
`THE WHOLE THING LAUNCHES IN OCTOBER OF 2003 AFTER
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 28
`
`

`

` 65
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`PATENT INFRINGEMENT? NO. NO.
`
`AND BY THE WAY, THE MICHELSON TRANSLATERAL IMPLANT
`
`IS USED IN AREAS THAT HAVE NOTHING TO DO WITH THE PSOAS
`
`MUSCLE. ALL RIGHT.
`
`NERVE MONITORS, THERE'S ANOTHER POINT AT WORK
`
`HERE. WE ARE ACCUSED OF INFRINGING THE NUVASIVE 236 PATENT,
`
`A PATENT ON NERVE MONITORING. NO ONE IN THIS COURTROOM WILL
`
`SAY THAT NUVASIVE WAS THE ONE TO INVENT NERVE MONITORING.
`
`YOU WON'T HEAR THAT. NERVE MONITORING HAS BEEN AROUND FOR A
`
`LONG, LONG TIME. NOT AN ISSUE.
`
`AND NUVASIVE ITSELF DOESN'T USE THE NERVE
`
`MONITORING PROCESS. THEY PATENTED IT IN 236. DOESN'T USE
`
`IT.
`
`NOW, DOES THAT EXCUSE US, ASSUMING IT DID
`
`INFRINGE, THE FACT THAT NUVASIVE DOESN'T USE THIS INVENTION
`
`WOULD GIVE US THE RIGHT TO USE IT? NO. NO. THAT'S NOT THE
`
`POINT.
`
`THE POINT IS WE'RE NOT USING WHAT THEY PATENTED.
`
`WE'RE NOT USING WHAT THEY SAY WE COPIED. DO YOU FOLLOW ME?
`
`THEY'RE ARE NOT PRACTICING THE 236. WE'RE ACCUSED OF
`
`COPYING WHAT THEY HAVE BY PRACTICING THE 236. IT'S A
`
`DIFFERENT SYSTEM. THERE ARE A NUMBER OF NEURO MONITORING
`
`PROCESSES OUT THERE.
`
`LET ME DIG INTO THE INFRINGEMENT ON THE 236.
`
`NEXT SLIDE.
`
`ELIZABETH CESENA, CSR 12266, (619) 237-0100
`USDC, SOUTHERN DISTRICT OF CA
`PO BOX 131037, SAN DIEGO, CA 92170
`
`Page 29
`
`

`

` 66
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`YOU'LL GET MORE DETAIL ABOUT THIS LATER.
`
`A KEY TO THE 236 IS THAT THE NERVE SIGNAL --
`
`WHAT'S NEURO MONITORING? NEURO MONITORING, YOU HAVE A PROBE
`
`THAT EMITS A SIGNAL. OKAY? AND AS THE PROBE COMES IN, YOU
`
`ARE GOING THROUGH TISSUE. IF THAT SIGNAL HITS A NERVE, THE
`
`NERVE REACTS.
`
`A MONITOR PICKS UP THE REACTION. WHEN THE MONITOR
`
`PICKS UP THE REACTION, YOU KNOW THAT YOU ARE CLOSE TO A
`
`NERVE, AND THAT HELPS THE SURGEON AVOID THE NERVE, IF THE
`
`SURGEON WISHES TO GO ABOUT IT THAT WAY.
`
`THE PARTICULAR TECHNIQUE IN A 236 THAT NUVASIVE
`
`DOESN'T PRACTICE REQUIRES THAT ARE AS SOON AS THE MONITOR
`
`PICKS UP A RESPONSE FROM THE NERVE, THAT THE SIGNAL STOP.
`
`OKAY. THAT'S THE INVENTION. AND IT REQUIRES THAT
`
`THE SIGNAL STOP FOR SAF

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket